LBI-HTA - Publications - Search - Type: HTA Newsletter Item
Number of items: 304.

Antes, G. (2003): [Funding for clinical research: A programme of the German Research Foundation (DFG). Editorial]. HTA-Newsletter 23: 1.

Breyer, E. (2007): [Nanotechnologies in medicine: Hopes and risks]. HTA-Newsletter 60: 2-3.

Dörflinger, R. (2005): [Poverty causes illness. Editorial]. HTA-Newsletter 42: 1-2.

Falkner, E. (2007): [Tissue engineering]. HTA-Newsletter 57: 3.

Falkner, E. and Wild, C. (2007): Cell salvage for minimising perioperative allogeneic blood transfers]. HTA-Newsletter 59: 3.

Felder-Puig, R. (2007): [Whole-body-CT screening. More harm than benefit?]. HTA-Newsletter 60: 2.

Felder-Puig, R. (2007): [Non-pharmacological interventions to prevent wandering in dementia]. HTA-Newsletter 59: 2-3.

Felder-Puig, R. (2007): [Back pain. Various methods of treatment]. HTA-Newsletter 57: 2-3.

Felder-Puig, R. (2007): [Artificial cervical discs. Recent study results]. HTA-Newsletter 55: 2.

Felder-Puig, R. (2007): [Hypertension and weight-loss. Treatment options]. HTA-Newsletter 54: 2-3.

Felder-Puig, R. (2007): [Age-related macular degeneration. Treatment and quality of life]. HTA-Newsletter 53: 2.

Felder-Puig, R. (2006): [Coronary surgery, specif. PTCA: Quality and frequencies]. HTA-Newsletter 52: 3-4.

Felder-Puig, R. (2006): [Radiology in Austria. Patients’ benefit and cost-effectiveness. Editorial]. HTA-Newsletter 51: 1.

Felder-Puig, R. (2006): [Arthroplasty register: A quality assurance instrument]. HTA-Newsletter 50: 2-3.

Felder-Puig, R. (2006): [Restrictive use of Alzheimer’s drugs]. HTA-Newsletter 49: 2-3.

Felder-Puig, R. (2006): [Prosthetic intervertebral disc replacement]. HTA-Newsletter 48: 2-3.

Frühwald, T. (2006): [Evidence-based medication in elderly patients. Editorial]. HTA-Newsletter 49: 1-2.

Fried, A. (2007): [The pharmaceutical industry puts pressure on publishers]. HTA-Newsletter 53: 1.

Fried, A. (2005): [Ethics in the context of medicine and economics. Editorial]. HTA-Newsletter 36: 1.

Gartlehner, G. (2007): [New vaccines: Horizon scanning]. HTA-Newsletter 59: 4.

Gartlehner, G. (2007): [Second-generation antidepressants]. HTA-Newsletter 57: 2.

Gartlehner, G. (2006): [Cesarean delivery on maternal request]. HTA-Newsletter 50: 2.

Gawlik, C. (2006): [Assessing disease management outcomes: Medicare disease management programmes. Editorial]. HTA-Newsletter 46: 1.

Gawlik, C. (2002): [Disease management programmes in Germany. Editorial]. HTA-Newsletter 07: 1-2.

Geiger-Gritsch, S. (2008): Horizon Scanning in Oncology - Concept Development. HTA-Newsletter 69: 3.

Geiger-Gritsch, S. (2008): Stent-graft Implantation for diseases of the ascending aorta. HTA-Newsletter 68: 2.

Geiger-Gritsch, S. (2008): [Testosterone-substitution for androgen deficiency in the ageing men]. HTA-Newsletter 66: 2.

Geiger-Gritsch, S. (2007): [Avastin® (Bevacizumab): Off-label use in cancer therapy]. HTA-Newsletter 58: 2.

Gerhardus, A. (2002): [Impact of health technology assessments on policy. Editorial]. HTA-Newsletter 06: 1-2.

Groth, S. (2007): [HPV immunisation and cervical cancer prevention. Editorial]. HTA-Newsletter 54: 1.

Groth, S. (2002): [Hormone replacement therapy for menopausal symptoms. Editorial]. HTA-Newsletter 13: 2.

Guba, B. (2006): [Anti-aging medicine: What´s behind it?]. HTA-Newsletter 52: 4.

Hinterreiter, G. (2008): Medical self-test kits - Expectations & actual benefit. HTA-Newsletter 72:3.

Hinterreiter, G. (2008): Incisional hernias - A comparison of different surgery methods. HTA-Newsletter 70: 5.

Jonas, S. (2004): [Genetic testing. Editorial]. HTA-Newsletter 31: 1.

Klepp, B. (2006): [Drug advertising: Law versus reality. Editorial]. HTA-Newsletter 50: 1.

Korencan, A. (2007): [HER2 diagnostics in breast cancer]. HTA-Newsletter 55: 3-4.

Korencan, A. (2007): [Diagnosis of cytomegalovirus disease in immunocompromised patients]. HTA-Newsletter 53: 4.

Langer, T. (2007): [Environmental safety of drugs]. HTA-Newsletter 57: 1.

Langer, T. (2006): [Stem cell transplantation for acute leukemia]. HTA-Newsletter 52: 2-3.

Langer, T. (2006): [Role of neuroimaging for headache]. HTA-Newsletter 51: 3-4.

Langer, T. (2006): [Cochlear implants]. HTA-Newsletter 50: 4.

Langer, T. (2006): [Hip protectors for preventing hip fractures]. HTA-Newsletter 49: 4.

Langer, T. (2006): [Bypass materials in vascular surgery]. HTA-Newsletter 48: 3-4.

Mad, P. (2007): [Health services research: Service improvement]. HTA-Newsletter 60: 4.

Mad, P. (2007): [Photodynamic therapy in the palliative treatment of malignant oesophageal stenosis]. HTA-Newsletter 58: 3-4.

Mad, P. (2007): [Telemonitoring for patients with chronic heart failure]. HTA-Newsletter 56: 4.

Mad, P. (2007): [Screening for Glaucoma]. HTA-Newsletter 55: 2-3.

Mad, P. (2007): [Robotic surgery in urology: Prostate interventions]. HTA-Newsletter 54: 4.

Mad, P. (2007): Drug Eluting Stents (DES): Safety aspects. HTA-Newsletter 53: 2-3.

Mad, P. (2006): [Computed tomographic angiography for coronary artery evaluation]. HTA-Newsletter 48: 4.

Mathis, S. (2007): [Interstitial brachytherapy in the treatment of localised prostate cancer]. HTA-Newsletter 57: 4.

Metz, S. and Mittermayer, H. (2007): [Antibiotic resistance: A challenge for health policy. Editorial]. HTA-Newsletter 58: 1.

Nagele, M. (2006): [Computed tomographic colonography (CTC) for colon cancer screening]. HTA-Newsletter 51: 4.

Perleth, M. (2004): [HTA and the evaluation of innovations. Editorial]. HTA-Newsletter 29: 1.

Pieber, T. R. (2002): [Disease management for diabetes mellitus. Editorial]. HTA-Newsletter 5: 1.

Radlberger, P. (2007): [Mass spectrometry for metabolic diseases in newborns]. HTA-Newsletter 60: 3-4.

Radlberger, P. (2007): [Wound treatment: Vacuum-assisted closure]. HTA-Newsletter 56: 3.

Radlberger, P. (2007): [Participation in screening programmes]. HTA-Newsletter 55: 4.

Radlberger, P. (2007): [Genotyping for Cytochrome P450 Polymorphisms]. HTA-Newsletter 53: 3.

Radlberger, P. (2006): [Predictive genetic diagnostics: Testing for breast cancer]. HTA-Newsletter 52: 2.

Radlberger, P. (2006): [Magnetic resonance imaging in patients with breast cancer]. HTA-Newsletter 51: 2-3.

Said, H. (2007): [Relationship between health and health care costs. Editorial]. HTA-Newsletter 55: 1.

Schimetta, W. (2005): [Non-interventional, observational studies of drugs. Editorial]. HTA-Newsletter 39: 1-2.

Siebenhofer-Kroitzsch, A. (2006): [Insulin analogues: Price and treatment strategy. Editorial]. HTA-Newsletter 52: 1.

Siebert, U. (2006): [Decision-analytic modelling: Aims, strengths and limitations. Editorial]. HTA-Newsletter 45: 1-2.

Sprenger, M. (2005): [Oseltamivir (Tamiflu)]. HTA-Newsletter 43: 1-2.

Trummer, U. (2003): [Evidence-based health promotion. Editorial]. HTA-Newsletter 16: 1-2.

Velasco-Garrido, M. and Busse, R. (2007): [Health baskets in 9 countries of the EU. Editorial]. HTA-Newsletter 56: 1.

Wild, C. (2007): [FDA: Safety warning on erythropoietin]. HTA-Newsletter 58: 4.

Wild, C. (2007): [Biosimilars]. HTA-Newsletter 54: 2.

Wild, C. (2007): [Growth hormones: Possible late effects]. HTA-Newsletter 54: 3-4.

Wild, C. (2006): [Artificial nutrition in geriatric care]. HTA-Newsletter 49: 3-4.

Wild, C. (2006): [Austrian HTA institute founded. The Ludwig Boltzmann Institute of HTA starts working. Editorial]. HTA-Newsletter 47: 1.

Wild, C. (2006): [Rheumatoid arthritis: Targeted immune modulators]. HTA-Newsletter 46: 2.

Wild, C. (2006): [Diagnostics of urinary incontinence]. HTA-Newsletter 46: 2-3.

Wild, C. (2006): [Pegaptanib (Macugen®) for age-related macular degeneration (AMD)]. HTA-Newsletter 46: 3-4.

Wild, C. (2006): [Carotid stenting for carotid artery stenosis]. HTA-Newsletter 46: 4.

Wild, C. (2006): [Infliximab for Crohn’s disease]. HTA-Newsletter 45: 2.

Wild, C. (2006): [Interferon-beta for multiple sklerosis]. HTA-Newsletter 45: 2-3.

Wild, C. (2006): [Cervical smear tests]. HTA-Newsletter 45: 3-4.

Wild, C. (2006): [Antiviral treatment for chronic hepatitis C]. HTA-Newsletter 45: 4.

Wild, C. (2006): [EUnetHTA 2006-2008. Editorial]. HTA-Newsletter 44: 1.

Wild, C. (2006): [Diagnosis of the menopause: FSH and LH levels]. HTA-Newsletter 44: 2.

Wild, C. (2006): [Acute care for the elderly: Models of multidisciplinary health care]. HTA-Newsletter 44: 3-4.

Wild, C. (2006): [Tube feeding in the demented elderly]. HTA-Newsletter 44: 4.

Wild, C. (2005): [Treatment of dental caries: Ozone therapy]. HTA-Newsletter 43: 2-3.

Wild, C. (2005): [Proton therapy]. HTA-Newsletter 43: 3.

Wild, C. (2005): [Cognitive training in senile dementia]. HTA-Newsletter 43: 4.

Wild, C. (2005): [Surgery for morbid obesity]. HTA-Newsletter 42: 2.

Wild, C. (2005): [Chemonucleolysis for herniated disc]. HTA-Newsletter 42: 2-3.

Wild, C. (2005): [Statins for acute coronary syndrome]. HTA-Newsletter 42: 3-4.

Wild, C. (2005): [Cerebral microdialysis: Neuromonitoring]. HTA-Newsletter 42: 4.

Wild, C. (2005): [Statement of the Viennese Bioethics Commission on advance directives. Editorial]. HTA-Newsletter 41: 1.

Wild, C. (2005): [Stroke rehabilitation] . HTA-Newsletter 41: 2.

Wild, C. (2005): [Immunoglobulin in neonates and preterm infants]. HTA-Newsletter 41: 2-3.

Wild, C. (2005): [Treatment of osteoporosis]. HTA-Newsletter 41: 3-4.

Wild, C. (2005): [Glucosamine sulphate for osteoarthritis]. HTA-Newsletter 41: 4.

Wild, C. (2005): [Medical progress. Editorial]. HTA-Newsletter 40: 1-2.

Wild, C. (2005): [Medical progress. Editorial]. HTA-Newsletter 40: 1-2.

Wild, C. (2005): [Avastin®/Bevacizumab for metastatic colorectal cancer]. HTA-Newsletter 40: 2.

Wild, C. (2005): [Erbitux®/Cetuximab for metastatic colorectal cancer]. HTA-Newsletter 40: 2-3.

Wild, C. (2005): [Herceptin®/Trastuzumab for metastatic breast cancer]. HTA-Newsletter 40: 3.

Wild, C. (2005): . HTA-Newsletter 40: 4.

Wild, C. (2005): [Minimally invasive treatment for herniated discs]. HTA-Newsletter 39: 2.

Wild, C. (2005): [Molar root treatment]. HTA-Newsletter 39: 2-3.

Wild, C. (2005): [Sleep disorders: Referral of patients to sleep laboratories]. HTA-Newsletter 39: 3-4.

Wild, C. (2005): [Hip ultrasound in newborns: An update]. HTA-Newsletter 39: 4.

Wild, C. (2005): [Obituary: Dr. Susanna Jonas. Editorial]. HTA-Newsletter 38: 1.

Wild, C. (2005): [Autologous blood donation]. HTA-Newsletter 38: 2.

Wild, C. (2005): [The morning-after pill: Emergency contraception]. HTA-Newsletter 38: 2-3.

Wild, C. (2005): [Nanotechnology in medical research]. HTA-Newsletter 38: 3-4.

Wild, C. (2005): [Recombinant activated C protein for severe sepsis]. HTA-Newsletter 38: 4.

Wild, C. (2005): [Financing of health care: Liberalisation and sociopolitical implications. Editorial]. HTA-Newsletter 37: 1.

Wild, C. (2005): [Neuromodulation in patients with Parkinson´s disease or chronic pain]. HTA-Newsletter 37: 2.

Wild, C. (2005): [Computer-aided detection (CAD) in mammography]. HTA-Newsletter 37: 2-3.

Wild, C. (2005): [Sonography of the acute abdomen]. HTA-Newsletter 37: 3-4.

Wild, C. (2005): [Quantitative polymerase chain reaction (Q-PCR) in fetal diagnosis of chromosomal abnormalities] . HTA-Newsletter 37: 4.

Wild, C. (2005): [Depression: Screening]. HTA-Newsletter 36: 2-3.

Wild, C. (2005): [Screening for abdominal aortic aneurysm (AAA)]. HTA-Newsletter 36: 2.

Wild, C. (2005): [Coronary heart disease. Risk models]. HTA-Newsletter 36: 3.

Wild, C. (2005): [Insulin pump. Intensive therapy for type 1 diabetes]. HTA-Newsletter 36: 4.

Wild, C. (2005): [6th Annual Meeting of the German Network for Evidence Based Medicine. Workshop: Bias spotting. Editorial]. HTA-Newsletter 35: 1.

Wild, C. (2005): [Case series studies]. HTA-Newsletter 35: 2.

Wild, C. (2005): [Methods for meta-analyses of diagnostic accuracy studies]. HTA-Newsletter 35: 2-3.

Wild, C. (2005): [Measuring patient-based outcomes]. HTA-Newsletter 35: 3-4.

Wild, C. (2005): [Randomised versus non-randomised studies] . HTA-Newsletter 35: 4.

Wild, C. (2005): [Contours of a basic health care benefit package. Editorial]. HTA-Newsletter 34: 1.

Wild, C. (2005): [Hyperthermia in the treatment of malignant tumours]. HTA-Newsletter 34: 2.

Wild, C. (2005): [Trigger point injections (TPI) for non-malignant musculoskeletal pain]. HTA-Newsletter 34: 2-3.

Wild, C. (2005): [Auditory brain stem implants]. HTA-Newsletter 34: 3.

Wild, C. (2005): [Provocation-neutralisation therapy for food allergy]. HTA-Newsletter 34: 4.

Wild, C. (2005): [Foundation of an Austrian HTA institute. Editorial]. HTA-Newsletter 33: 1-2.

Wild, C. (2005): [Intraoperative ablation for atrial fibrillation]. HTA-Newsletter 33: 2.

Wild, C. (2005): [Genotyping for cytochrome P450 polymorphisms]. HTA-Newsletter 33: 2-3.

Wild, C. (2005): [Prosthetic intervertebral disc replacement]. HTA-Newsletter 33: 3-4.

Wild, C. (2005): [Impact of HTA]. HTA-Newsletter 33: 4.

Wild, C. (2004): [Communication and error management culture. Editorial]. HTA-Newsletter 32: 1.

Wild, C. (2004): [Endometrial ablation techniques in the treatment of uterine bleeding]. HTA-Newsletter 32: 2.

Wild, C. (2004): [Rituximab (MabThera®) as treatment for non-Hodgkin's lymphoma]. HTA-Newsletter 32: 3.

Wild, C. (2004): [Directives for end-of-life care: Living will and health care power of attorney]. HTA-Newsletter 32: 3-4.

Wild, C. (2004): [Breast cancer care: Quality indicators]. HTA-Newsletter 32: 4.

Wild, C. (2004): [Implantable defibrillators/ICD]. HTA-Newsletter 31: 2.

Wild, C. (2004): [Vacuum assisted closure for treating wounds]. HTA-Newsletter 31: 2-3.

Wild, C. (2004): [Drug eluting stents: An economic analysis]. HTA-Newsletter 31: 3-4.

Wild, C. (2004): [Genetic testing for predisposition]. HTA-Newsletter 31: 4.

Wild, C. (2004): [Methods of hysterectomy]. HTA-Newsletter 30: 2.

Wild, C. (2004): [Sclerotherapy for leg varicose veins]. HTA-Newsletter 30: 2-3.

Wild, C. (2004): [Telephone triage services]. HTA-Newsletter 30: 3-4.

Wild, C. (2004): [Home-based chemotherapy: Evaluation criteria]. HTA-Newsletter 30: 4.

Wild, C. (2004): [Short acting insulin analogues in the treatment of diabetes mellitus]. HTA-Newsletter 29: 2.

Wild, C. (2004): [Whole-body computed tomography as a screening test]. HTA-Newsletter 29: 2-3.

Wild, C. (2004): [Prevention and therapy of Hepatitis C]. HTA-Newsletter 29: 3-4.

Wild, C. (2004): [New technologies in cervical cancer screening]. HTA-Newsletter 29: 4.

Wild, C. (2004): [The Oregon drug class review project as initiative for generics. Editorial]. HTA-Newsletter 28: 1.

Wild, C. (2004): [Liposuction in cosmetic surgery]. HTA-Newsletter 28: 2.

Wild, C. (2004): [Low-intensity pulsed ultrasound for bone healing in pseudarthrosis]. HTA-Newsletter 28: 2-3.

Wild, C. (2004): [Robodoc®: Robotics in surgery]. HTA-Newsletter 28: 3-4.

Wild, C. (2004): [Teriparatide (Forsteo®) in the treatment of osteoporosis]. HTA-Newsletter 28: 4.

Wild, C. (2004): [The myth of cancer prevention: Heresy or guidance to maturity. Editorial]. HTA-Newsletter 27: 1.

Wild, C. (2004): [Bisphosphonates: Treatment of bone metastases]. HTA-Newsletter 27: 2.

Wild, C. (2004): [ERCP vs. MRCP: Diagnostics of biliary tract diseases]. HTA-Newsletter 27: 2-3.

Wild, C. (2004): [CT and MR angiography. Diagnostics of renal artery stenosis]. HTA-Newsletter 27: 3-4.

Wild, C. (2004): [Photodynamic therapy/PDT]. HTA-Newsletter 27: 4.

Wild, C. (2004): [Shared decision making. Editorial]. HTA-Newsletter 26: 1.

Wild, C. (2004): [The excimer laser: Treatment of short-sightedness]. HTA-Newsletter 26: 2.

Wild, C. (2004): [LeukoScan®: Diagnostics of osteomyelitis]. HTA-Newsletter 26: 2-3.

Wild, C. (2004): [Age-related macular degeneration: An update]. HTA-Newsletter 26: 3-4.

Wild, C. (2004): [Radiofrequency ablation: Therapy of liver tumours] . HTA-Newsletter 26: 4.

Wild, C. (2004): [Transparency in the pharmaceutical industry. Editorial]. HTA-Newsletter 25: 1-2.

Wild, C. (2004): [Non-ionic contrast media]. HTA-Newsletter 25: 2.

Wild, C. (2004): [Screening for colorectal cancer in Austria]. HTA-Newsletter 25: 2-3.

Wild, C. (2004): [Electrostimulation after stroke]. HTA-Newsletter 25: 3-4.

Wild, C. (2004): [Stereotactic radiosurgery]. HTA-Newsletter 25: 4.

Wild, C. (2004): [Mammography screening in Austria. Editorial]. HTA-Newsletter 24: 1-2.

Wild, C. (2004): [Epithelial cell cytology in breast cancer risk assessment]. HTA-Newsletter 24: 2.

Wild, C. (2004): [Sentinel node biopsy (SNB) in breast cancer]. HTA-Newsletter 24: 2-3.

Wild, C. (2004): [Breast cancer diagnosis by magnetic resonance imaging or positron emission tomography (PET)]. HTA-Newsletter 24: 3-4.

Wild, C. (2004): [Intraoperative radiotherapy in early stage breast cancer]. HTA-Newsletter 24: 4.

Wild, C. (2003): [Electric stimulation for faecal incontinence]. HTA-Newsletter 23: 2-3.

Wild, C. (2003): [Cryosurgery for prostate cancer]. HTA-Newsletter 23: 2.

Wild, C. (2003): [Cardiac resynchronisation therapy (CRT) for heart failure]. HTA-Newsletter 23: 3-4.

Wild, C. (2003): [Psychotherapy]. HTA-Newsletter 23: 4.

Wild, C. (2003): [HTA interactive link collection. Editorial]. HTA-Newsletter 22: 1.

Wild, C. (2003): [Hip arthroplasty]. HTA-Newsletter 22: 2.

Wild, C. (2003): [Extracorporeal shock wave therapy (ESWT) for pseudarthrosis]. HTA-Newsletter 22: 2-3.

Wild, C. (2003): [Endoscopic sinus surgery for nasal polyps]. HTA-Newsletter 22: 3-4.

Wild, C. (2003): [High-dose chemotherapy]. HTA-Newsletter 22: 4.

Wild, C. (2003): [Tools for decision-making. Editorial]. HTA-Newsletter 21: 1.

Wild, C. (2003): [Recombinant human growth hormone (GH) therapy]. HTA-Newsletter 21: 2.

Wild, C. (2003): [High-dose lymphoablative therapy (HDLT) for severe autoimmune diseases]. HTA-Newsletter 21: 2-3.

Wild, C. (2003): [Graftskin (Apligraf®) in the treatment of venous leg ulcers]. HTA-Newsletter 21: 3-4.

Wild, C. (2003): [Computed tomography in screening for lung cancer]. HTA-Newsletter 21: 4.

Wild, C. (2003): [HTA and the commercialisation of new technologies. Editorial]. HTA-Newsletter 20: 1.

Wild, C. (2003): [MARS® liver support]. HTA-Newsletter 20: 2.

Wild, C. (2003): [The digestive endoscopic imaging capsule]. HTA-Newsletter 20: 2-3.

Wild, C. (2003): [Autologous chondrocyte transplantation of the knee]. HTA-Newsletter 20: 3-4.

Wild, C. (2003): [Ambulatory versus stationary haemodialysis for people with end-stage renal failure]. HTA-Newsletter 20: 4.

Wild, C. (2003): [Clinical economics. Editorial]. HTA-Newsletter 19: 1-2.

Wild, C. (2003): [Liquid-based cytology in cervical screening]. HTA-Newsletter 19: 2.

Wild, C. (2003): [Extracorporeal immunoadsorption treatment]. HTA-Newsletter 19: 2-3.

Wild, C. (2003): [Viscosupplementation in the treatment of osteoarthritis]. HTA-Newsletter 19: 3-4.

Wild, C. (2003): [Tumour vaccination]. HTA-Newsletter 19: 4.

Wild, C. (2003): [Patient information in screening programmes. Editorial]. HTA-Newsletter 18: 1-2.

Wild, C. (2003): [Activated protein C for severe sepsis]. HTA-Newsletter 18: 2.

Wild, C. (2003): [Virtual colonoscopy]. HTA-Newsletter 18: 2-3.

Wild, C. (2003): [Treatment of chronic pain: Multidisciplinary programmes]. HTA-Newsletter 18: 3-4.

Wild, C. (2003): [Troponin testing in acute coronary syndromes]. HTA-Newsletter 18: 4.

Wild, C. (2003): [Decision making in health care. Editorial]. HTA-Newsletter 17: 1.

Wild, C. (2003): [Racz-catheter for chronic back pain]. HTA-Newsletter 17: 2.

Wild, C. (2003): [Vertebroplasty and kyphoplasty]. HTA-Newsletter 17: 2-3.

Wild, C. (2003): [Pegylated interferon alpha for chronic hepatitis C]. HTA-Newsletter 17: 3-4.

Wild, C. (2003): [Anaesthetics in day surgery]. HTA-Newsletter 17: 4.

Wild, C. (2003): [Mental illness and the identification of risk groups]. HTA-Newsletter 16: 2.

Wild, C. (2003): [Interventions for preventing obesity in children and adolescents]. HTA-Newsletter 16: 2-3.

Wild, C. (2003): [Lifestyle and physical activity]. HTA-Newsletter 16: 3-4.

Wild, C. (2003): [Health promotion in companies and schools]. HTA-Newsletter 16: 4.

Wild, C. (2003): [Foundation of the Austrian network "HTA in hospitals". Editorial]. HTA-Newsletter 15: 1.

Wild, C. (2003): [Diagnosis of osteoporosis]. HTA-Newsletter 15: 2.

Wild, C. (2003): [Digital mammography/DM]. HTA-Newsletter 15: 2-3.

Wild, C. (2003): [Medical one-way devices]. HTA-Newsletter 15: 3.

Wild, C. (2003): [Endovascular surgery for abdominal aortic aneurysm/AAA]. HTA-Newsletter 15: 4.

Wild, C. (2003): [Organisational performance and its appraisal. Editorial]. HTA-Newsletter 14: 1.

Wild, C. (2003): [Electromagnetic field therapy]. HTA-Newsletter 14: 2.

Wild, C. (2003): [Newborn hearing screening]. HTA-Newsletter 14: 2-3.

Wild, C. (2003): [Use of genotypic resistance testing to optimise HIV-therapy]. HTA-Newsletter 14: 3.

Wild, C. (2003): [Implantable cardioverter defibrillator]. HTA-Newsletter 14: 4.

Wild, C. (2002): [Glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes]. HTA-Newsletter 13: 2-3.

Wild, C. (2002): [Coated stents]. HTA-Newsletter 13: 3-4.

Wild, C. (2002): [Pharmacogenetics]. HTA-Newsletter 13: 4.

Wild, C. (2002): [New drugs in the treatment of cancer. Editorial]. HTA-Newsletter 12: 1.

Wild, C. (2002): [Trastuzumab for breast cancer]. HTA-Newsletter 12: 2.

Wild, C. (2002): [Ultrasound screening for hip dysplasia in newborns]. HTA-Newsletter 12: 2-3.

Wild, C. (2002): [Treatment of varicose veins]. HTA-Newsletter 12: 3-4.

Wild, C. (2002): [Visual electrodiagnosis]. HTA-Newsletter 12: 4.

Wild, C. (2002): [Rationing in health care. Editorial]. HTA-Newsletter 11: 1-2.

Wild, C. (2002): [Proton radiation]. HTA-Newsletter 11: 2.

Wild, C. (2002): [Tinnitus retraining therapy]. HTA-Newsletter 11: 2-3.

Wild, C. (2002): [Living donor transplantation]. HTA-Newsletter 11: 3-4.

Wild, C. (2002): [Infliximab for Crohn's disease]. HTA-Newsletter 11: 4.

Wild, C. (2002): [The KoA-committee in Germany. Editorial}. HTA-Newsletter 10: 1-2.

Wild, C. (2002): [Intensive care units: An evidence-based needs assessment for Austria]. HTA-Newsletter 10: 2.

Wild, C. (2002): [Tacrolimus ointment for the treatment of atopic dermatitis/AD]. HTA-Newsletter 10: 2-3.

Wild, C. (2002): [Tandem mass spectometry (TMS) and neonatal screening]. HTA-Newsletter 10: 3-4.

Wild, C. (2002): [Stapled haemorrhoidectomy]. HTA-Newsletter 10: 4.

Wild, C. (2002): [ISTAHC 2002: Trends and tendencies. Editorial]. HTA-Newsletter 09: 1.

Wild, C. (2002): [Evidence-based dentistry]. HTA-Newsletter 09: 2.

Wild, C. (2002): [Bupropion in smoking cessation]. HTA-Newsletter 09: 2-3.

Wild, C. (2002): [Psoriasis]. HTA-Newsletter 09: 3.

Wild, C. (2002): [Youth suicide prevention]. HTA-Newsletter 09: 4.

Wild, C. (2002): [Guidelines for manufacturers and medical associations on submission of evidence. Editorial]. HTA-Newsletter 08: 1.

Wild, C. (2002): [Robotic surgery]. HTA-Newsletter 08: 2.

Wild, C. (2002): [Positron emission tomography/PET]. HTA-Newsletter 08: 2-3.

Wild, C. (2002): [Drug therapy for adiposity]. HTA-Newsletter 08: 3-4.

Wild, C. (2002): [Surgical treatment of obesity]. HTA-Newsletter 08: 4.

Wild, C. (2002): [Predictive genetic testing for breast and prostate cancer]. HTA-Newsletter 07: 2.

Wild, C. (2002): [Ritalin for attention deficit hyperactivity disorder/ADHD]. HTA-Newsletter 07: 2-3.

Wild, C. (2002): [Vaccines for preventing influenza]. HTA-Newsletter 07: 3-4.

Wild, C. (2002): [Pallidotomy in Parkinson's disease]. HTA-Newsletter 07: 4.

Wild, C. (2002): [Laser-induced thermotherapy (LITT) in the treatment of malignant tumours]. HTA-Newsletter 06: 2.

Wild, C. (2002): [In vitro fertilisation and intracytoplastic sperm injection]. HTA-Newsletter 06: 2-3.

Wild, C. (2002): [The EndoCinch suturing system]. HTA-Newsletter 06: 3-4.

Wild, C. (2002): [COX-2 inhibitors in the treament of arthritis]. HTA-Newsletter 06: 4.

Wild, C. (2002): [Glitazone in the treatment of type 2 diabetes mellitus]. HTA-Newsletter 05: 2.

Wild, C. (2002): [Alpha lipoic acid in the treatment of neuropathy]. HTA-Newsletter 05: 2-3.

Wild, C. (2002): [Insulin analogues]. HTA-Newsletter 05: 3.

Wild, C. (2002): [Diabetic foot syndrome: Early diagnosis and treatment costs]. HTA-Newsletter 05: 3-4.

Wild, C. (2002): [Is critical journalism contradictory to the reporting of innovations? Editorial]. HTA-Newsletter 04: 1.

Wild, C. (2002): [Clopidogrel (Plavix): Secondary prevention of coronary heart disease]. HTA-Newsletter 04: 2.

Wild, C. (2002): [Acupuncture]. HTA-Newsletter 04: 2-4.

Wild, C. (2002): [Screening for colorectal cancer]. HTA-Newsletter 04: 4.

Wild, C. (2002): [Antifungal agents in the treatment of invasive aspergillosis]. HTA-Newsletter 04: 4.

Wild, C. (2001): [Stem cell research, quo vadis? Editorial]. HTA-Newsletter 03: 1-2.

Wild, C. (2001): [Hyperbaric oxygen]. HTA-Newsletter 03: 2.

Wild, C. (2001): [Sacral neuromodulation in the treatment of urinary incontinence]. HTA-Newsletter 03: 2-3.

Wild, C. (2001): [Botulinim toxin and other spasmolytics for treatment of spasticity]. HTA-Newsletter 03: 3.

Wild, C. (2001): [Drug treatments for Alzheimer's disease]. HTA-Newsletter 03: 3-4.

Wild, C. (2001): [HTA link list]. HTA-Newsletter 03: 4.

Wild, C. (2001): [Innovations and (expensive) followers. Editorial]. HTA-Newsletter 02: 1-2.

Wild, C. (2001): [Autologous chondrocyte transplantation (ACI) in treating cartilage damage]. HTA-Newsletter 02: 2.

Wild, C. (2001): [Tension free vaginal tape (TVT) for urinary incontinence of women]. HTA-Newsletter 02: 2-3.

Wild, C. (2001): [Brachytherapy for prostate cancer]. HTA-Newsletter 02: 3.

Wild, C. (2001): [Cytomegalovirus prophylaxis and therapy]. HTA-Newsletter 02: 3-4.

Wild, C. (2001): [Generics and cost reduction: A project in Austria]. HTA-Newsletter 02: 4.

Wild, C. (2001): [Limitations of evidence based medicine. Editorial]. HTA-Newsletter 01: 1.

Wild, C. (2001): [Erythropoietin for anaemic tumour patients]. HTA-Newsletter 01: 2.

Wild, C. (2001): [Chronic fatigue syndrome]. HTA-Newsletter 01: 2.

Wild, C. (2001): [Age related macular degeneration. Photodynamic therapy]. HTA-Newsletter 01: 3.

Wild, C. (2001): [Treatment of autism]. HTA-Newsletter 01: 3-4.

Wild, C. (2001): [Extracorporeal shock wave therapy in orthopedics]. HTA-Newsletter 01: 4.

Wild, C. (2001): [European Collaboration in HTA]. HTA-Newsletter 01: 4.

Wild, C. (2001): [Health Technology Assessment and decision making. Editorial]. HTA-Newsletter 00: 1-2.

Wild, C. and Adlbrecht, C. (2007): [Radiopharmaceuticals in palliative care]. HTA-Newsletter 58: 2-3.

Wild, C. and Adlbrecht, C. (2007): [Laser vaporisation of benign prostatic hyperplasia]. HTA-Newsletter 56: 2.

Wild, C. and Antes, G. (2004): [Registration of all clinical trials. Editorial]. HTA-Newsletter 30: 1-2.

Wild, C. and Zechmeister, I. (2007): [Allocation of resources and equity. Editorial]. HTA-Newsletter 59: 1.

Zechmeister, I. (2008): [Vaccination against HPV in Austria]. HTA-Newsletter 64: 2.

Zechmeister, I. (2007): [Treatment of mental disorders. Editorial]. HTA-Newsletter 60: 1.

Zechmeister, I. (2007): [Hepatitis C therapy]. HTA-Newsletter 59: 2.

Zechmeister, I. (2007): [Age-related macular degeneration (AMD): Diagnostics]. HTA-Newsletter 56: 2-3.

Zechmeister, I. (2006): [Back pain: Radiology often unnecessary]. HTA-Newsletter 51: 2.

Zechmeister, I. (2006): [HPV immunisation: Different strategies]. HTA-Newsletter 50: 3-4.

Zechmeister, I. (2006): [Current guidelines for health economic evaluation. Austria in comparison with Canada. Editorial]. HTA-Newsletter 48: 1.

Zechmeister, I. (2006): [Statins: Economic evaluation]. HTA-Newsletter 48: 2.

This list was generated on Mon May 29 15:01:14 2017 CEST.